AstraZeneca to invest $100m to expand Sydney manufacturing plant

Pharmaceutical company AstraZeneca is investing an additional $100m to expand its manufacturing facility in North Ryde, Sydney, to develop inhaler products for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news